Risk stratification for secondary prevention with ticagrelor and aspirin: A closer look to patient subsets from the PEGASUS-TIMI 54 trial

Int J Cardiol. 2015 Dec 15:201:276-8. doi: 10.1016/j.ijcard.2015.08.057. Epub 2015 Aug 5.

Authors

Davide Capodanno¹, Piera Capranzano², Sergio Buccheri², Corrado Tamburino²

Affiliations

¹ Ferrarotto Hospital, University of Catania, Catania, Italy. Electronic address: [email protected].
² Ferrarotto Hospital, University of Catania, Catania, Italy.

PMID: 26301657
DOI: 10.1016/j.ijcard.2015.08.057

No abstract available

Keywords: PEGASUS; Secondary prevention; Ticagrelor.

Publication types

Letter

MeSH terms

Adenosine / analogs & derivatives*
Adenosine / therapeutic use
Aged
Aspirin / therapeutic use*
Female
Humans
Male
Myocardial Infarction / prevention & control*
Purinergic P2Y Receptor Antagonists / therapeutic use
Randomized Controlled Trials as Topic
Secondary Prevention / methods*
Ticagrelor
Treatment Outcome

Substances

Purinergic P2Y Receptor Antagonists
Ticagrelor
Adenosine
Aspirin